Literature DB >> 12791193

Paroxysmal Dyskinesias in Children.

Tony M. McGrath1, Leon S. Dure.   

Abstract

Paroxysmal dyskinesias are rare movement disorders. The onset of paroxysmal dyskinesias in childhood are typically idiopathic (sporadic or familial), whereas those in adulthood are usually secondary to an identifiable cause. Paroxysmal dyskinesias are classified according to precipitating factors, and these include paroxysmal kinesigenic dyskinesia, paroxysmal nonkinesigenic dyskinesia, paroxysmal exertion-induced dyskinesia, and paroxysmal hypnogenic dyskinesia. The pathophysiology remains unknown; however, there is increasing evidence that channelopathies may play a role, which explains the response to anticonvulsant medications in certain kindreds. Pharmacologic treatment with anticonvulsant medications, clonazepam, tetrabenazine, trihexyphenidyl, or levodopa is reviewed herewith. Paroxysmal dyskinesias go by many names, but a rational classification does exist. Of those that respond to medications, the majority of paroxysmal dyskenesias respond to anticonvulsant medications. Channelopathies have been implemented as a cause in paroxysmal dyskinesias.

Entities:  

Year:  2003        PMID: 12791193     DOI: 10.1007/s11940-003-0032-x

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  15 in total

1.  Oxcarbazepine therapy in paroxysmal kinesigenic choreoathetosis.

Authors:  A Gökçay; F Gökçay
Journal:  Acta Neurol Scand       Date:  2000-05       Impact factor: 3.209

2.  A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q.

Authors:  G T Fouad; S Servidei; S Durcan; E Bertini; L J Ptácek
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

3.  Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24.

Authors:  H A Phillips; I E Scheffer; K M Crossland; K P Bhatia; D R Fish; C D Marsden; S J Howell; J B Stephenson; J Tolmie; G Plazzi; O Eeg-Olofsson; R Singh; I Lopes-Cendes; E Andermann; F Andermann; S F Berkovic; J C Mulley
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

4.  Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1.

Authors:  H a Tomita; S Nagamitsu; K Wakui; Y Fukushima; K Yamada; M Sadamatsu; A Masui; T Konishi; T Matsuishi; M Aihara; K Shimizu; K Hashimoto; M Mineta; M Matsushima; T Tsujita; M Saito; H Tanaka; S Tsuji; T Takagi; Y Nakamura; S Nanko; N Kato; Y Nakane; N Niikawa
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

5.  Multicenter study of paroxysmal dyskinesias in Japan--clinical and pedigree analysis.

Authors:  S Nagamitsu; T Matsuishi; K Hashimoto; Y Yamashita; M Aihara; K Shimizu; M Mizuguchi; H Iwamoto; S Saitoh; Y Hirano; H Kato; Y Fukuyama; M Shimada
Journal:  Mov Disord       Date:  1999-07       Impact factor: 10.338

Review 6.  Paroxysmal dyskinesias as a paradigm of paroxysmal movement disorders.

Authors:  M Vidailhet
Journal:  Curr Opin Neurol       Date:  2000-08       Impact factor: 5.710

Review 7.  Familial (idiopathic) paroxysmal dyskinesias: an update.

Authors:  K P Bhatia
Journal:  Semin Neurol       Date:  2001       Impact factor: 3.420

8.  Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2.

Authors:  H A Phillips; I E Scheffer; S F Berkovic; G E Hollway; G R Sutherland; J C Mulley
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

9.  Paroxysmal dyskinesias: clinical features and classification.

Authors:  M Demirkiran; J Jankovic
Journal:  Ann Neurol       Date:  1995-10       Impact factor: 10.422

10.  Nocturnal paroxysmal dystonia.

Authors:  E Lugaresi; F Cirignotta; P Montagna
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-04       Impact factor: 10.154

View more
  1 in total

1.  Paroxysmal dyskinesias.

Authors:  Shyamal H Mehta; John C Morgan; Kapil D Sethi
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.